weissman genome wide crispr activation crispra library (Addgene inc)
94
Structured Review
Addgene inc
weissman genome wide crispr activation crispra library
Weissman Genome Wide Crispr Activation Crispra Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/weissman+genome+wide+crispr+activation+crispra+library/Human+Genome-wide+CRISPRa-v2+Libraries+(Pooled+Libraries+%2383978%2C+%231000000091)/pm41898529-174-1-17
Average 94 stars, based on 28 article reviews
Weissman Genome Wide Crispr Activation Crispra Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/weissman+genome+wide+crispr+activation+crispra+library/Human+Genome-wide+CRISPRa-v2+Libraries+(Pooled+Libraries+%2383978%2C+%231000000091)/pm41898529-174-1-17
Average 94 stars, based on 28 article reviews
weissman genome wide crispr activation crispra library - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Genome Wide:Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: .. The Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: .. The CRISPR:Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: .. The Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: .. The Activation Assay:Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: .. The Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: .. The |